An interventional study of BEAUTIFY application in Breast Cancer, sponsored by Centre Hospitalier Universitaire de Nīmes. Completed at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-01.
Sponsored by Centre Hospitalier Universitaire de Nīmes · Not applicable, Interventional, and Other
This project is a follow-on study of the BEAUTIFY-2 study (NCT04957186). The "BEAUTIFY" (BrEast cAncer qUaliTy of lIfe aFter surgerY) program was built by a committee of experts on the basis of reflections carried out within 2 focus groups. An application was developed to track patient reported outcome measures.
The study investigators now wish to evaluate the feasibility and impact on pain and quality of life of the "BEAUTIFY" care pathway on a larger cohort. The study hypothesis is that multidisciplinary care organization will improve the management and the quality of life post-breast cancer surgery.
12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.
This study's enrollment of 50 is below the median of 72 across 9,303 interventional studies indexed under Breast Neoplasms.
Browse Breast Neoplasms studies →Centre Hospitalier Universitaire de Nīmes is the lead sponsor of 587 studies on the registry; 96 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Device: BEAUTIFY application
Interview with the coordinating nurse in the postoperative period to install the BEAUTIFY application on the patient's smartphone and to train her to record any Patients will monitor their symptoms weekly. In case of toxicity grade \> 2, the nurse will contact the patient for further information.
Patient compliance with the program
Yes/No: study will be considered feasible if at least 80% of patients complete the program
Time frame: End of study (12 months)
Patient satisfaction with the intervention
Yes/No: study will be considered feasible if at least 80% of patients are satisfied.
Time frame: End of study (12 months)
Compliance with completing the BEAUTIFY application
% of weeks where information is recorded out of the total number of weeks
Time frame: End of study (12 months)
Patient quality of life following surgery
European Organisation For Research And Treatment Of Cancer Quality of Life of Cancer Patients (EORTC QLQ C30): score of 1-7 for each item
Time frame: Baseline
Patient quality of life following surgery
EORTC QLQ C30: score of 1-7 for each item
Time frame: 1 month
Patient quality of life following surgery
EORTC QLQ C30: score of 1-7 for each item
Time frame: 3 months
Patient quality of life following surgery
EORTC QLQ C30: score of 1-7 for each item
Time frame: 6 months
Satisfaction of patients with their care
EORTC PATSAT-C33: score 0-100
Time frame: 1 month
Satisfaction of patients with their care
EORTC PATSAT-C33: score 0-100
Time frame: 3 months
Satisfaction of patients with their care
EORTC PATSAT-C33: score 0-100
Time frame: 6 months
Rate of post-operative complications
% patients with a complication noted in medical file
Time frame: 6 months
Type of post-operative complications
List of the complications affected patients as noted in medical file
Time frame: 6 months
Readmission rate for surgical or medical reason
% patients readmitted
Time frame: 6 months
Return to work and/or social activities
Date: Patients contacted by email or telephone
Time frame: 1 year
This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire de Nīmes